At the baseline visit, compared to individuals who did not develop the outcome, those who developed had a longer duration of diabetes, higher BMI, WHR, WHtR, waist and VAI, worse glucose and lipid control, lower eGFR and insulin sensitivity, despite similar blood pressure and distribution of sex (Table 1). This evidence concerns the gene INS and diabetes mellitus.